This NDC is on FDA's drug shortage list (posted Jun 13, 2018)
Product Information
LIDOCAINE HCL 1% VIAL is a generic product labeled by Eugia US LLC, priced at $0.2441 per ML under NDC 55150025110. Its NADAC has been published 201 times since Jan 18, 2023.
FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Eugia US LLCNDC
55150025110
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
11/18/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207182FDA Approved
10/30/2017
TE Code
AP
On Market Since
10/30/2017
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% VIAL has been published 201 times since Jan 18, 2023, and over the history we have for it it has risen 16.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2441 per ML |
|---|---|
| All-time high | $0.2441 (Nov 18, 2026) |
| All-time low | $0.1197 (Feb 18, 2026) |
| 52-week high | $0.2441 |
| 52-week low | $0.1197 |
| Median price | $0.1768 |
| Average price | $0.1667 |
| Largest weekly change | +77.1% (Nov 18, 2026) |
| Weeks tracked | 201 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Eugia US LLC, is $0.2441 per ML (NDC 55150025110), effective Nov 18, 2026.
How has the price of LIDOCAINE HCL 1% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 16.7%. It has been tracked across 201 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?
Since Jan 18, 2023, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.1197 (Feb 18, 2026) to a high of $0.2441 (Nov 18, 2026), with a median of $0.1768 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0691 per ML — about 72% below LIDOCAINE HCL 1% VIAL.
Who manufactures LIDOCAINE HCL 1% VIAL?
LIDOCAINE HCL 1% VIAL (NDC 55150025110) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Is LIDOCAINE HCL 1% VIAL in shortage?
Yes — NDC 55150025110 is currently listed in FDA's drug shortage database (posted Jun 13, 2018).